Citations 2
PRE‐TREATMENT HEMOGLOBIN AND OUTCOME IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH ANTHRACYCLINE CONTAINING CHEMOTHERAPY
Ulrichsen, Sinna Pilgaard , Larsen, Thomas Stauffer , Himmelstrup, Bodil , Rønnov-Jessen, Dorte, Nowakowski, Grzegorz S. , Thompson, Carrie A. , Madsen, J. , Pedersen, Robert Schou, Gørløv, Jette Sønderskov, d’Amore, Francesco, Clausen, Michael Roost , Maurer, Matthew J. , Link, Brian K. , Feldman, Andrew L. , Slager, Susan L. , Pedersen, Per Trøllund , Cerhan, James R.
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 418-420
Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study
Clausen, Michael Roost , Plesner, Torben , Pasanen, Annika , Kuismanen, T., Bentzen, Hans, Jørgensen, Judit , Sillesen, Ida Blok, Himmelstrup, Bodil , Rønnov‐Jessen, Dorthe, Jensen, Kiersten, Pettinger, Adam, Ludvigsen, Maja , Leppä, Sirpa , d’Amore, Francesco, Joergensen, Judit Mészáros , Madsen, Charlotte Bernhard , Clausen, Michael Roost
Blood Advances | July 5, 2018 | Volume: 2 | Issue: 13 | Pages: 1562-1571
10.1182/bloodadvances.2018017673
Key PointsPatients who received R-chemo followed by MR had an improved 5-year PFS and OS independent of prognostic factors. A reduction of the risk of HT was observed among the MR patients of the training, but not of the validation, cohort.